TG THERAPEUTICS INC. - COMMON STOCK

TG Therapeutics to Participate in the 2023 Cantor Global Healthcare Conference

22 Sep 2023 06:30:00 By Nasdaq GlobeNewswire

TG Therapeutics Provides Business Update and Reports Second Quarter 2023 Financial Results

01 Aug 2023 06:15:00 By Nasdaq GlobeNewswire

TG Therapeutics and Neuraxpharm Announce Ex-US Commercialization Agreement for BRIUMVI® (ublituximab-xiiy)

01 Aug 2023 06:00:01 By Nasdaq GlobeNewswire

TG Therapeutics to Host Conference Call on Second Quarter 2023 Financial Results and Business Update

31 Jul 2023 07:30:00 By Nasdaq GlobeNewswire

TG Therapeutics to Participate in the 2023 Jefferies Healthcare Conference

05 Jun 2023 06:30:00 By Nasdaq GlobeNewswire

TG Therapeutics Announces Presentation of Data from the ULTIMATE I & II Phase 3 Trials of BRIUMVI® (ublituximab-xiiy) in Multiple Sclerosis at the 2023 Consortium of Multiple Sclerosis Centers Annual Meeting

02 Jun 2023 08:15:20 By Nasdaq GlobeNewswire

TG Therapeutics Announces European Commission Approval for BRIUMVI® (ublituximab-xiiy) for the Treatment of Relapsing Forms of Multiple Sclerosis in Adults

01 Jun 2023 08:15:00 By Nasdaq GlobeNewswire

TG Therapeutics Announces Data from the ULTIMATE I & II Phase 3 Trials of BRIUMVI® (ublituximab-xiiy) in Multiple Sclerosis to be Presented at the 2023 Consortium of Multiple Sclerosis Centers Annual Meeting

31 May 2023 06:30:00 By Nasdaq GlobeNewswire

NetDania - New 12 months High: TG THERAPEUTICS INC. - COMMON STOCK

04 May 2023 08:46:02 By NetDania Notify

TG Therapeutics to Participate in the Bank of America Securities 2023 Health Care Conference

04 May 2023 06:30:00 By Nasdaq GlobeNewswire

NetDania - New 12 months High: TG THERAPEUTICS INC. - COMMON STOCK

03 May 2023 08:59:02 By NetDania Notify

NetDania - New 12 months High: TG THERAPEUTICS INC. - COMMON STOCK

02 May 2023 08:45:06 By NetDania Notify

NetDania - New 12 months High: TG THERAPEUTICS INC. - COMMON STOCK

01 May 2023 08:45:55 By NetDania Notify

TG Therapeutics Provides Business Update and Reports First Quarter 2023 Financial Results

01 May 2023 06:30:00 By Nasdaq GlobeNewswire

TG Therapeutics to Host Conference Call on First Quarter 2023 Financial Results and Business Update

28 Apr 2023 15:30:00 By Nasdaq GlobeNewswire

NetDania - New 12 months High: TG THERAPEUTICS INC. - COMMON STOCK

28 Apr 2023 12:01:28 By NetDania Notify

TG Therapeutics Announces Issuance of Permanent J-Code for BRIUMVI® (ublituximab-xiiy) from Centers for Medicare and Medicaid Services

27 Apr 2023 06:30:00 By Nasdaq GlobeNewswire

NetDania - New 12 months High: TG THERAPEUTICS INC. - COMMON STOCK

25 Apr 2023 08:45:28 By NetDania Notify

TG Therapeutics Announces Presentation of Data from the ULTIMATE I & II Phase 3 Trials of BRIUMVI® (ublituximab-xiiy) in Multiple Sclerosis at the American Academy of Neurology 75th Annual Meeting

25 Apr 2023 07:00:01 By Nasdaq GlobeNewswire

TG Therapeutics Announces Positive CHMP Opinion for BRIUMVI™ (ublituximab-xiiy) for the Treatment of Relapsing Forms of Multiple Sclerosis in Adults

31 Mar 2023 06:30:06 By Nasdaq GlobeNewswire